Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares RAP1GDS1, MSN, Ipilimumab, Nivolumab and the tag subtype-page.
Shares PD-L1 CPS (combined positive score), Tislelizumab, Paclitaxel / nab-paclitaxel, Nivolumab and the tag subtype-page.
Shares Alcohol reduction, pricing and cancer warning labels, Smoking cessation in cancer patients, Cisplatin, Pembrolizumab and the tag subtype-page.
Shares PD-L1 CPS (combined positive score), Fluorouracil (5-FU), Paclitaxel / nab-paclitaxel, Cisplatin and the tag subtype-page.
Shares Smoking cessation in cancer patients, Nivolumab, Cisplatin, Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin, Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Pembrolizumab and the tag subtype-page.
Shares Ipilimumab, Nivolumab, Cisplatin, Pembrolizumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.